Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung

References

• JemalASiegelRWardECancer statistics, 2008CA Cancer J Clin200858719618287387
   PubMed Web of Science ®Google Scholar
• ReckMHeigenerDFMokTSoriaJCRabeKFManagement of non-small-cell lung cancer: recent developmentsLancet201338270971923972814
   PubMed Web of Science ®Google Scholar
• OkamotoIMitsudomiTNakagawaKFukuokaMThe emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutationTher Adv Med Oncol2010230130721789142
   PubMedGoogle Scholar
• TsaoASPapadimitrakopoulouVAThe future of NSCLC: molecular profiles guiding treatment decisionsOncology (Williston Park)20112560761421888260
   PubMed Web of Science ®Google Scholar
• SodaMChoiYLEnomotoMIdentification of the transforming EML4-ALK fusion gene in non-small-cell lung cancerNature200744856156617625570
   PubMed Web of Science ®Google Scholar
• ZhangXZhangSYangXFusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expressionMol Cancer2010918820624322
   PubMed Web of Science ®Google Scholar
• KimDAhnMYangPUpdated results of a global phase II study with crizotinin in advanced ALK-positive non-small cell lung cancer (NSCLC)Ann Oncol201223 Abstr 1230 PD
   Web of Science ®Google Scholar
• WongDWLeungELSoKKUniversity of Hong Kong Lung Cancer Study GroupThe EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRASCancer20091151723173319170230
   PubMed Web of Science ®Google Scholar
• KwakELBangYJCamidgeDRAnaplastic lymphoma kinase inhibition in non-small-cell lung cancerN Engl J Med2010363181693170320979469
   PubMed Web of Science ®Google Scholar
• ShawATYeapBYSolomonBJImpact of crizotinib on survival in patients with advanced, ALK-positive NSCLC compared with historical controlsJ Clin Oncol201129suppl abstr 7507
   Google Scholar
• CrinoLKimDRielyGJInitial Phase II results with crizotinib in advanced ALK-positive non-small cell lung cancer (NSCLC): PROFILE 1005J Clin Oncol201129suppl abstr 7514
   PubMed Web of Science ®Google Scholar
• ShawATKimDWNakagawaKCrizotinib versus chemotherapy in advanced ALK-positive lung cancerN Engl J Med2013368252385239423724913
   PubMed Web of Science ®Google Scholar
• SahooRHariniVVBabuVCScreening for EGFR mutations in lung cancer, a report from IndiaLung Cancer201173331631921315473
   PubMed Web of Science ®Google Scholar
• ChouguleAPrabhashKNoronhaVFrequency of EGFR mutations in 907 lung adenocarcinoma patients of Indian ethnicityPLoS One2013810e7616424124538
   PubMed Web of Science ®Google Scholar
• DovalDCAzamSBatraUEpidermal growth factor receptor mutation in lung adenocarcinoma in India: a single center studyJ Carcinog2013121223961259
   PubMedGoogle Scholar
• DesaiSSShahASPrabhashKJambhekarNAA year of anaplastic large cell kinase testing for lung carcinoma: pathological and technical perspectivesIndian J Cancer2013502808623979196
   PubMed Web of Science ®Google Scholar
• TanakaHHayashiAMorimotoTA case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion geneBMC Cancer20121255823181703
   PubMed Web of Science ®Google Scholar
• LeeJKKimTMKohYDifferential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK trans-locationLung Cancer201277246046322622260
   PubMed Web of Science ®Google Scholar
• PopatSVieira de AraújoAMinTLung adenocarcinoma with concurrent exon 19 EGFR mutation and ALK rearrangement responding to erlotinibJ Thorac Oncol20116111962196322005476
   PubMed Web of Science ®Google Scholar
• Varella-GarciaMChoYLuXALK gene rearrangements in unselected caucasians with non-small cell lung carcinoma (NSCLC)J Clin Oncol20102818s (suppl; abstr 10533)
   Web of Science ®Google Scholar
• ShawATYeapBYMino-KenudsonMClinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALKJ Clin Oncol2009274247425319667264
   PubMed Web of Science ®Google Scholar
• RodigSJMino-KenudsonMDacicSUnique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western populationClin Cancer Res2009155216522319671850
   PubMed Web of Science ®Google Scholar
• LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibN Engl J Med20043502129213915118073
   PubMed Web of Science ®Google Scholar
• PaezJGJännePALeeJCEGFR mutations in lung cancer: correlation with clinical response to gefitinib therapyScience20043041497150015118125
   PubMed Web of Science ®Google Scholar
• DoganSShenRAngDCMolecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancersClin Cancer Res2012186169617723014527
   PubMed Web of Science ®Google Scholar
• Cortes-FunesHGomezCRosellREpidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patientsAnn Oncol2005161081108615851406
   PubMed Web of Science ®Google Scholar
• JangTWOakCHChangHKSuoSJJungMHEGFR and KRAS mutations in patients with adenocarcinoma of the lungKorean J Intern Med200924485419270482
   PubMedGoogle Scholar
• WuSGGowCHYuCJFrequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinomaEur Respir J20083292493018508816
   PubMed Web of Science ®Google Scholar
• UsuiKUshijimaTTanakaYThe frequency of epidermal growth factor receptor mutation of nonsmall cell lung cancer according to the underlying pulmonary diseasesPulm Med2011201129013222191026
   PubMedGoogle Scholar
• HuangYSYangJJZhangXCImpact of smoking status and pathologic type on epidermal growth factor receptor mutations in lung cancerChin Med J (Engl)20111242457246021933587
   PubMed Web of Science ®Google Scholar
• AggarwalSPatilSMinhansSPungliyaMSoumitraNA study of EGFR mutation in nonsmoker NSCLC: striking disparity between north and south India patientsJ Clin Oncol201230suppl abstr e18041
   Google Scholar
• PungliyaMSachinMSoumittraNShekarPShyamAA study of incidence of EGFR mutations in non-smoker adenocarcinoma of the lung: disparity between north and south indian patientsJ Cancer Ther Res201434
   Google Scholar
• MehtaJMolecular epidemiology of epidermal growth factor receptor mutations in lung cancers in Indian populationIndian J Cancer201350210210623979199
   PubMed Web of Science ®Google Scholar
• SekineIYamamotoNNishioKSaijoNEmerging ethnic differences in lung cancer therapyBr J Cancer2008991757176218985035
   PubMed Web of Science ®Google Scholar
• SmitsAJKummerJAHinrichsJWEGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinomaCell Oncol (Dordr)20123518919622528563
   PubMed Web of Science ®Google Scholar
• TanakaTMatsuokaMSutaniAFrequency of and variables associated with the EGFR mutation and its subtypesInt J Cancer201012665165519609951
   PubMed Web of Science ®Google Scholar
• KrishnamurthyAVijayalakshmiRGadigiVRanganathanRSagarTGThe relevance of “Nonsmoking-associated lung cancer” in India: a single-centre experienceIndian J Cancer201249828822842173
   PubMed Web of Science ®Google Scholar
• MalikPSSharmaMCMohantiBKClinico-pathological profile of lung cancer at AIIMS: a changing paradigm in IndiaAsian Pac J Cancer Prev20131448949423534779
   PubMedGoogle Scholar
• RikovaKGuoAZengQGlobal survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancerCell20071311190120318083107
   PubMed Web of Science ®Google Scholar
• BangYJThe potential for crizotinib in non-small cell lung cancer: a perspective reviewTher Adv Med Oncol20113627929122084642
   PubMedGoogle Scholar
• FukuiTYatabeYKobayashiYClinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogeneLung Cancer20127731932522483782
   PubMed Web of Science ®Google Scholar
• PaikJHChoiCMKimHClinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinomaLung Cancer20127640340922129856
   PubMed Web of Science ®Google Scholar